| scholarly article | Q13442814 |
| P2093 | author name string | Masaki Murata | |
| Akira Andoh | |||
| Masaya Sasaki | |||
| Tomoyuki Tsujikawa | |||
| Atsushi Nishida | |||
| Hirotsugu Imaeda | |||
| Osamu Inatomi | |||
| Shigeki Bamba | |||
| Hiromitsu Ban | |||
| Makoto Shioya | |||
| Ken-Ichiro Takahashi | |||
| P2860 | cites work | Guidelines for the management of inflammatory bowel disease in adults | Q22242049 |
| Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee | Q33523446 | ||
| Cyclosporine in severe ulcerative colitis refractory to steroid therapy | Q34060783 | ||
| A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis | Q35768942 | ||
| Update on biologic pathways in inflammatory bowel disease and their therapeutic relevance | Q36116908 | ||
| Prognostic factors for colectomy in refractory ulcerative colitis treated with calcineurin inhibitors | Q36285603 | ||
| Onodera's prognostic nutritional index as a risk factor for mortality in peritoneal dialysis patients | Q36381919 | ||
| Systematic review: cytomegalovirus infection in inflammatory bowel disease | Q37310964 | ||
| The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management | Q37814541 | ||
| Infliximab or cyclosporine for acute severe ulcerative colitis: a retrospective analysis. | Q37957998 | ||
| Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management | Q38049776 | ||
| Infliximab versus cyclosporine as rescue therapy in acute severe steroid-refractory ulcerative colitis: a systematic review and meta-analysis | Q38056807 | ||
| Treatment guidelines in inflammatory bowel disease: the Japanese perspectives | Q38163743 | ||
| Factors associated with poor outcomes in adults with newly diagnosed ulcerative colitis. | Q38216765 | ||
| Role of epithelial cells in the pathogenesis and treatment of inflammatory bowel disease | Q38542147 | ||
| Clinical course and prognosis in ulcerative colitis: results from population-based and observational studies | Q42360841 | ||
| Factors affecting the efficacy of cyclosporin A therapy for refractory ulcerative colitis | Q43108441 | ||
| Decreasing colectomy rates for ulcerative colitis: a population-based time trend study | Q44097483 | ||
| A study on cases developed pulmonary tuberculosis after receiving gastrectomy | Q44947814 | ||
| Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study. | Q46130626 | ||
| The nutritional index 'CONUT' is useful for predicting long-term prognosis of patients with end-stage liver diseases. | Q51025320 | ||
| Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. | Q53122367 | ||
| TNF-alpha is an important pathogenic factor contributing to reactivation of cytomegalovirus in inflamed mucosa of colon in patients with ulcerative colitis: lesson from clinical experience. | Q54471669 | ||
| An index of disease activity in patients with ulcerative colitis | Q68231324 | ||
| [Postoperative nutritional assessment in gastric and colorectal cancer] | Q70303344 | ||
| [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients] | Q70507813 | ||
| Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapy | Q81611327 | ||
| Cytomegalovirus disappearance after treatment for refractory ulcerative colitis in 2 patients treated with infliximab and 1 patient with leukapheresis | Q82225861 | ||
| [The significance of Onodera's prognostic nutritional index for the treatment of gastrointestinal cancer] | Q83077922 | ||
| Predictive factors of response to intravenous ciclosporin in severe ulcerative colitis: the development of a novel prediction formula | Q84946549 | ||
| P433 | issue | 2 | |
| P921 | main subject | ulcerative colitis | Q1477 |
| P304 | page(s) | 829-834 | |
| P577 | publication date | 2016-05-16 | |
| P1433 | published in | Experimental and Therapeutic Medicine | Q23979083 |
| P1476 | title | Prognostic factors affecting early colectomy in patients with moderate to severe ulcerative colitis treated with calcineurin inhibitors | |
| P478 | volume | 12 |
| Q33828933 | Sarcopenia is a predictive factor for intestinal resection in admitted patients with Crohn's disease | cites work | P2860 |
Search more.